K
Koichi Hirata
Researcher at Sapporo Medical University
Publications - 735
Citations - 21379
Koichi Hirata is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 68, co-authored 717 publications receiving 18834 citations. Previous affiliations of Koichi Hirata include Showa University.
Papers
More filters
Journal ArticleDOI
Tokyo Guidelines 2018 management bundles for acute cholangitis and cholecystitis
Toshihiko Mayumi,Kohji Okamoto,Tadahiro Takada,Steven M. Strasberg,Joseph S. Solomkin,David Schlossberg,Henry A. Pitt,Masahiro Yoshida,Harumi Gomi,Fumihiko Miura,O. James Garden,Seiki Kiriyama,Masamichi Yokoe,Itaru Endo,Horacio J. Asbun,Yukio Iwashita,Taizo Hibi,Akiko Umezawa,Kenji Suzuki,Takao Itoi,Jiro Hata,Ho-Seong Han,Tsann Long Hwang,Christos Dervenis,Koji Asai,Yasuhisa Mori,Wayne Shih Wei Huang,Giulio Belli,Shuntaro Mukai,Palepu Jagannath,Daniel Cherqui,Kazuto Kozaka,Todd H. Baron,Eduardo de Santibañes,Ryota Higuchi,Keita Wada,Dirk J. Gouma,Daniel J. Deziel,Kui Hin Liau,Go Wakabayashi,Robert Padbury,Eduard Jonas,Avinash Supe,Harjit Singh,Toshifumi Gabata,Angus C.W. Chan,Wan Yee Lau,Sheung Tat Fan,Miin Fu Chen,Chen Guo Ker,Yoo Seok Yoon,In Seok Choi,Myung-Hwan Kim,Dong Sup Yoon,Seigo Kitano,Masafumi Inomata,Koichi Hirata,Kazuo Inui,Yoshinobu Sumiyama,Masakazu Yamamoto +59 more
TL;DR: Critical parts of the bundles in TG18 include the diagnostic process, severity assessment, transfer of patients if necessary, and therapeutic approach at each time point should improve the prognosis of acute cholangitis and cholecystitis.
Journal ArticleDOI
Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
Toru Beppu,Go Wakabayashi,Kiyoshi Hasegawa,Naoto Gotohda,Toru Mizuguchi,Yutaka Takahashi,Fumitoshi Hirokawa,Nobuhiko Taniai,Manabu Watanabe,Masato Katou,Hiroaki Nagano,Goro Honda,Hideo Baba,Norihiro Kokudo,Masaru Konishi,Koichi Hirata,Masakazu Yamamoto,Kazuhisa Uchiyama,Eiji Uchida,Shinya Kusachi,Keiichi Kubota,Masaki Mori,Keiichi Takahashi,Ken Kikuchi,Hiroaki Miyata,Takeshi Takahara,Masafumi Nakamura,Hironori Kaneko,Hiroki Yamaue,Masaru Miyazaki,Tadahiro Takada +30 more
TL;DR: The aim of the present study was to clarify the surgical outcome and long‐term prognosis of laparoscopic liver resection compared with conventional open Liver resection in patients with colorectal liver metastases (CRLM).
Journal ArticleDOI
A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins
Satomi Idenoue,Yoshihiko Hirohashi,Toshihiko Torigoe,Yuriko Sato,Yasuaki Tamura,Hiroyuki Hariu,Masaaki Yamamoto,Takehiro Kurotaki,Tetsuhiro Tsuruma,Hiroko Asanuma,Takayuki Kanaseki,Hideyuki Ikeda,Kiyoteru Kashiwagi,Minoru Okazaki,Kazuaki Sasaki,Takashi Sato,Tousei Ohmura,Fumitake Hata,Koji Yamaguchi,Koichi Hirata,Noriyuki Sato +20 more
TL;DR: Overexpression of survivin was detected in surgically resected primary tumor specimens of most breast and colorectal cancers and some gastric cancers as assessed by immunohistochemical study, and data indicate that survivin expressed in tumor tissues is antigenic in cancer patients, and survivin-2B80-88-specific CTLs are present in PBMCs of various cancer patients.
Journal ArticleDOI
Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis
Arata Shimo,Chizu Tanikawa,Toshihiko Nishidate,Toshihiko Nishidate,Meng-Lay Lin,Koichi Matsuda,Jae-Hyun Park,Tomomi Ueki,Tomomi Ueki,Tomohiko Ohta,Koichi Hirata,Mamoru Fukuda,Yusuke Nakamura,Toyomasa Katagiri +13 more
TL;DR: The findings suggest that overexpression of KIF2C/MCAK might be involved in breast carcinogenesis and is a promising therapeutic target for breast cancers.
Journal ArticleDOI
Phase II study of oral S‐1 for treatment of metastatic colorectal carcinoma
Kuniaki Shirao,Atsushi Ohtsu,Hideho Takada,Yasushi Mitachi,Kosei Hirakawa,Noboru Horikoshi,Takeshi Okamura,Koichi Hirata,Soh Saitoh,Hiroharu Isomoto,Atsushi Satoh +10 more
TL;DR: The objective response rate and toxicity associated with the oral fluoropyrimidine S‐1 (a combination of tegafur, 5‐chloro‐2,4‐dihydroxypyridine, and potassium oxonate) in patients with previously untreated metastatic colorectal carcinoma was evaluated.